SYNTA PHARMACEUTICALS CORP 4
4 · SYNTA PHARMACEUTICALS CORP · Filed Nov 5, 2015
Insider Transaction Report
Form 4
Morenstein Scott D
Director
Transactions
- Award
Non-Employee Director Stock Option (Right to Buy)
2015-11-03+40,000→ 40,000 totalExercise: $0.67Exp: 2025-11-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1. The option vests as to 25% of the shares on November 3, 2016 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.